14 May 2024 --- The Investor Action on Antimicrobial Resistance (IAAMR) initiative is calling on global leaders to combat antimicrobial resistance (AMR) by unveiling seven recommendations to address the global systemic risk of the AMR crisis on human health, economic stability and investment portfolios. This comes ahead of the UN General Assembly’s meeting on antimicrobial resistance (AMR) in September. AMR is recognized as a “leading threat” to global human health, claiming 1.27 million lives in 2019, a number projected to rise to ten million annually by 2050.
